This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock LOGC vs. HEPS, KRUS, MYTE, HLF, PLAY, FIGS, ETD, BLMN, SPTN, and CARSShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include D-Market Elektronik Hizmetler ve Ticaret A.S. (HEPS), Kura Sushi USA (KRUS), MYT Netherlands Parent B.V. (MYTE), Herbalife (HLF), Dave & Buster's Entertainment (PLAY), FIGS (FIGS), Ethan Allen Interiors (ETD), Bloomin' Brands (BLMN), SpartanNash (SPTN), and Cars.com (CARS). These companies are all part of the "retail/wholesale" sector. LogicBio Therapeutics vs. Its Competitors D-Market Elektronik Hizmetler ve Ticaret A.S. Kura Sushi USA MYT Netherlands Parent B.V. Herbalife Dave & Buster's Entertainment FIGS Ethan Allen Interiors Bloomin' Brands SpartanNash Cars.com LogicBio Therapeutics (NASDAQ:LOGC) and D-Market Elektronik Hizmetler ve Ticaret A.S. (NASDAQ:HEPS) are both small-cap retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, community ranking, valuation, analyst recommendations and dividends. Is LOGC or HEPS more profitable? D-Market Elektronik Hizmetler ve Ticaret A.S. has a net margin of -3.28% compared to LogicBio Therapeutics' net margin of -141.03%. D-Market Elektronik Hizmetler ve Ticaret A.S.'s return on equity of -30.48% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LogicBio Therapeutics-141.03% -81.98% -52.13% D-Market Elektronik Hizmetler ve Ticaret A.S. -3.28%-30.48%-5.30% Do analysts rate LOGC or HEPS? D-Market Elektronik Hizmetler ve Ticaret A.S. has a consensus target price of $3.50, suggesting a potential upside of 22.81%. Given D-Market Elektronik Hizmetler ve Ticaret A.S.'s stronger consensus rating and higher possible upside, analysts plainly believe D-Market Elektronik Hizmetler ve Ticaret A.S. is more favorable than LogicBio Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicBio Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00D-Market Elektronik Hizmetler ve Ticaret A.S. 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals have more ownership in LOGC or HEPS? 46.1% of LogicBio Therapeutics shares are owned by institutional investors. Comparatively, 40.5% of D-Market Elektronik Hizmetler ve Ticaret A.S. shares are owned by institutional investors. 8.1% of LogicBio Therapeutics shares are owned by insiders. Comparatively, 36.3% of D-Market Elektronik Hizmetler ve Ticaret A.S. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, LOGC or HEPS? D-Market Elektronik Hizmetler ve Ticaret A.S. has higher revenue and earnings than LogicBio Therapeutics. D-Market Elektronik Hizmetler ve Ticaret A.S. is trading at a lower price-to-earnings ratio than LogicBio Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicBio Therapeutics$287M0.78-$317M-$5.79-1.46D-Market Elektronik Hizmetler ve Ticaret A.S.$55.81B0.02$3.27M-$0.16-17.81 Does the MarketBeat Community prefer LOGC or HEPS? LogicBio Therapeutics received 80 more outperform votes than D-Market Elektronik Hizmetler ve Ticaret A.S. when rated by MarketBeat users. Likewise, 63.64% of users gave LogicBio Therapeutics an outperform vote while only 50.00% of users gave D-Market Elektronik Hizmetler ve Ticaret A.S. an outperform vote. CompanyUnderperformOutperformLogicBio TherapeuticsOutperform Votes9163.64% Underperform Votes5236.36% D-Market Elektronik Hizmetler ve Ticaret A.S.Outperform Votes1150.00% Underperform Votes1150.00% Does the media favor LOGC or HEPS? In the previous week, D-Market Elektronik Hizmetler ve Ticaret A.S. had 3 more articles in the media than LogicBio Therapeutics. MarketBeat recorded 4 mentions for D-Market Elektronik Hizmetler ve Ticaret A.S. and 1 mentions for LogicBio Therapeutics. D-Market Elektronik Hizmetler ve Ticaret A.S.'s average media sentiment score of 1.26 beat LogicBio Therapeutics' score of 0.00 indicating that D-Market Elektronik Hizmetler ve Ticaret A.S. is being referred to more favorably in the news media. Company Overall Sentiment LogicBio Therapeutics Neutral D-Market Elektronik Hizmetler ve Ticaret A.S. Positive Which has more volatility & risk, LOGC or HEPS? LogicBio Therapeutics has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Comparatively, D-Market Elektronik Hizmetler ve Ticaret A.S. has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500. SummaryD-Market Elektronik Hizmetler ve Ticaret A.S. beats LogicBio Therapeutics on 12 of the 17 factors compared between the two stocks. Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LOGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$222.85M$73.93B$24.80B$8.49BDividend YieldN/A4.84%168.53%4.17%P/E Ratio-1.4616.4923.7919.64Price / Sales0.781.814.24152.20Price / CashN/A31.1419.4134.64Price / Book0.955.376.074.60Net Income-$317M$2.05B$784.05M$248.06M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics0.8401 of 5 stars$8.48+7.6%N/A+45.7%$222.85M$287M-1.4662Gap DownHigh Trading VolumeHEPSD-Market Elektronik Hizmetler ve Ticaret A.S.1.7262 of 5 stars$2.63-1.1%$3.50+33.1%+26.3%$845.24M$55.81B-17.5310,800News CoveragePositive NewsKRUSKura Sushi USA1.629 of 5 stars$66.72+1.0%$77.20+15.7%-5.5%$806.31M$258.44M-98.122,100Positive NewsAnalyst RevisionMYTEMYT Netherlands Parent B.V.1.9774 of 5 stars$9.35-0.4%$14.00+49.7%+61.3%$801.29M$881.44M-21.741,240HLFHerbalife4.4906 of 5 stars$7.71-1.3%$11.50+49.2%-27.4%$785.24M$4.95B3.1010,100Positive NewsPLAYDave & Buster's Entertainment4.0277 of 5 stars$21.68-1.3%$33.00+52.2%-39.0%$748.59M$2.13B10.7323,258Earnings ReportAnalyst ForecastGap DownFIGSFIGS1.1668 of 5 stars$4.36+0.1%$4.50+3.3%-4.0%$707.91M$561.17M72.58310ETDEthan Allen Interiors4.0602 of 5 stars$25.71-1.6%$32.00+24.5%-5.9%$653.68M$622.92M10.804,240Positive NewsBLMNBloomin' Brands3.1446 of 5 stars$7.63flat$13.75+80.2%-54.7%$648.02M$3.93B-69.3687,000Positive NewsSPTNSpartanNash3.4499 of 5 stars$19.06-2.1%$10.00-47.5%-7.1%$645.26M$9.65B-1,906.0016,500Positive NewsCARSCars.com3.3845 of 5 stars$10.16-0.9%$18.30+80.2%-48.7%$645.13M$718M17.511,700Gap Down Related Companies and Tools Related Companies D-Market Elektronik Hizmetler ve Ticaret A.S. Alternatives Kura Sushi USA Alternatives MYT Netherlands Parent B.V. Alternatives Herbalife Alternatives Dave & Buster's Entertainment Alternatives FIGS Alternatives Ethan Allen Interiors Alternatives Bloomin' Brands Alternatives SpartanNash Alternatives Cars.com Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOGC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LOGC Stock Free LOGC Stock Alerts